Arthur is a second year medical student at Boston University School of Medicine with a strong interest in oncology research. At the Dana-Farber, Arthur is currently working to discover genetic markers in patients with Diffuse Large B-cell Lymphoma (DLBCL) via deep sequencing of patient samples. His project involves using knockout techniques such as the CRISPR/Cas9 system to help characterize candidate regulatory and tumor suppressor genes, including those involved in immune checkpoint dysregulation.
Prior to medical school, and under the guidance of Dr. Frederick Alt from Harvard Medical School, Arthur investigated B-lymphocyte development with a focus on the DNA repair mechanisms and epigenetics of V(D)J recombination, as well as their implications on B-lymphocyte genomic stability.
Arthur received his undergraduate degree in analytical chemistry and biochemistry from Boston University, where he received the Beckman Scholar Award for his research in natural product organic synthesis and drug discovery. His work focused on the total synthesis of DNA double strand break-inducing natural products and their derivatives. In his spare time, Arthur serves as a writer and lead editor for The Beat (see @ thebeatatbusm.com), a medical student-led online publication. In his downtime, he enjoys hiking.